About Association Since its founding in 1989, the Taiwan Bio Industry Organization (Taiwan BIO) has been promoting the interests of its members from industry, the government and academia as well as promoting the development of the biomedical industries and their contribution to Taiwan’s economy and people. The more than 100 organizations and 3,000 individuals that make up Taiwan BIO membership represent the entire life sciences industry spectrum, including from the biotechnology, pharmaceutical, diagnostics, medical devices and materials, agricultural biotechnology, and nutraceuticals sectors. | Since its founding in 1989, the Taiwan Bio Industry Organization (Taiwan BIO) has been promoting the interests of its members from industry, the government and academia as well as promoting the development of the biomedical industries and their contribution to Taiwan’s economy and people. The more than 100 organizations and 3,000 individuals that make up Taiwan BIO membership represent the entire life sciences industry spectrum, including from the biotechnology, pharmaceutical, diagnostics, medical devices and materials, agricultural biotechnology, and nutraceuticals sectors. Promoting the interests of our members Taiwan BIO works tirelessly for the interests of its members. With deep connections to government policy makers at all levels, Taiwan BIO advocates strongly for policies that will lead not only to the continued growth of the industry – both locally and internationally – but also to better opportunities for its members. Taiwan BIO pledges to represent equally all its members whether from Taiwan or abroad. Promoting international exchange and cooperation One of TBIO’s key responsibilities is organizing the annual BIO Asia–Taiwan international conference and exhibition, an annual week-long festival of biotech-themed events held in Taipei. Through this gathering, Taiwan BIO helps facilitate networking, licensing and cooperation opportunities between investors, researchers, biotech companies and other key stakeholders, with the event also playing an important role in improving Taiwan’s visibility within the global biotechnology community. Taiwan BIO also helps organize delegations to attend important overseas events, including a large combined industry-government delegation to the BIO International Convention held annually in North America. Promoting communication between government and industry In addition, Taiwan BIO organizes regular conferences, seminars and meetings inviting key industry leaders and government representatives to address members’ interests and concerns. In this way, Taiwan BIO acts as a bridge connecting the private sector, academia, government, and international interests. Cultivating biotechnology industry talent In 2015 Taiwan BIO helped establish the Bio Industry Academy (BIA), a training organization with a mission to better prepare local talent for employment in Taiwan’s growing biopharmaceutical sector, and to upgrade the industry as a whole. Training topics offered by BIA to date include new drug development, manufacturing processes, industry-related business, finance and management, among others. BIA is currently offering over 300 hours of courses each year and has so far helped prepare more than 200 specialists to high-level placement within this demanding industry. Encouraging outstanding performance and innovation Taiwan BIO organizes the annual Taiwan Bio-Industry Organization Awards, with the awards ceremony coinciding with BIO Asia–Taiwan. Winners are recognized in Outstanding Company of the Year, Emerging Company of the Year, and Innovation of the Year categories. In doing so, Taiwan BIO aims to recognize local achievements and encourage innovation within this important industry, helping facilitate its further growth and the development of the entire biotechnology ecosystem. | Since its founding in 1989, the Taiwan Bio Industry Organization (Taiwan BIO) has been promoting the interests of its members from industry, the government and academia as well as promoting the development of the biomedical industries and their contribution to Taiwan’s economy and people. The more than 100 organizations and 3,000 individuals that make up Taiwan BIO membership represent the entire life sciences industry spectrum, including from the biotechnology, pharmaceutical, diagnostics, medical devices and materials, agricultural biotechnology, and nutraceuticals sectors. Taiwan BIO works tirelessly for the interests of its members. With deep connections to government policy makers at all levels, Taiwan BIO advocates strongly for policies that will lead not only to the continued growth of the industry – both locally and internationally – but also to better opportunities for its members. Taiwan BIO pledges to represent equally all its members whether from Taiwan or abroad. One of TBIO’s key responsibilities is organizing the annual BIO Asia–Taiwan international conference and exhibition, an annual week-long festival of biotech-themed events held in Taipei. Through this gathering, Taiwan BIO helps facilitate networking, licensing and cooperation opportunities between investors, researchers, biotech companies and other key stakeholders, with the event also playing an important role in improving Taiwan’s visibility within the global biotechnology community. Taiwan BIO also helps organize delegations to attend important overseas events, including a large combined industry-government delegation to the BIO International Convention held annually in North America. In addition, Taiwan BIO organizes regular conferences, seminars and meetings inviting key industry leaders and government representatives to address members’ interests and concerns. In this way, Taiwan BIO acts as a bridge connecting the private sector, academia, government, and international interests. In 2015 Taiwan BIO helped establish the Bio Industry Academy (BIA), a training organization with a mission to better prepare local talent for employment in Taiwan’s growing biopharmaceutical sector, and to upgrade the industry as a whole. Training topics offered by BIA to date include new drug development, manufacturing processes, industry-related business, finance and management, among others. BIA is currently offering over 300 hours of courses each year and has so far helped prepare more than 200 specialists to high-level placement within this demanding industry. Taiwan BIO organizes the annual Taiwan Bio-Industry Organization Awards, with the awards ceremony coinciding with BIO Asia–Taiwan. Winners are recognized in Outstanding Company of the Year, Emerging Company of the Year, and Innovation of the Year categories. In doing so, Taiwan BIO aims to recognize local achievements and encourage innovation within this important industry, helping facilitate its further growth and the development of the entire biotechnology ecosystem.
Taiwan Bio-Manufacturing Corporation (TBMC)
Enabling reliable development and manufacturing of advanced therapies and complex biologics through a next-generation CRDMO platform. Taiwan Bio-Manufacturing Corporation (TBMC) is a Taiwan-based pure-play CRDMO focused on supporting global pharmaceutical and biotechnology partners in advancing next-generation therapeutics. Built upon Taiwan’s strong biotechnology research foundation and world-class manufacturing ecosystem, TBMC integrates experienced GMP expertise with advanced production technologies. TBMC provides end-to-end CRDMO solutions across cell therapy, mRNA therapeutics, viral vectors, plasmid DNA, and complex biologics including ADCs and bispecific antibodies. With modular, flexible, and digital GMP facilities, strong IP protection, and an Asia-based manufacturing presence, TBMC enables global partners to accelerate development timelines, scale manufacturing capacity, and support regulatory compliance across international markets. Partner with TBMC to strengthen your global manufacturing strategy for next-generation therapies.
TAIWAN CAROL ELECTRONICS CO.,LTD
Carol Electronics is a Taiwanese company with over 50 years of expertise in designing, developing, and manufacturing high-quality electroacoustic products. Specializing in microphones, speakers, and amplifiers, Carol Electronics has successfully addressed many common challenges in the industry, delivering an unmatched acoustic experience for its users. We take pride in offering both OEM services and developing our own brand, Carol, known for innovation and quality. Our proprietary Capsule technology is one of our greatest achievements, positioning us as a global leader in electroacoustic solutions. At Carol Electronics, we are committed to excellence and customer satisfaction. Contact us today to discuss your requirements and how we can collaborate to enhance your business with innovative, high-performance solutions. | Brands:Taiwan Carol | Taiwan Carol Electronics Co., Ltd.
Taiwan Cell Manufacturing Co. Ltd
At Taiwan Cell Manufacturing Co. (tcmc), we specialize in delivering premium-quality lentiviral vectors (LVVs) and cell therapy products tailored to meet your needs. LVVs play an important role in genetic engineering of T cells, and we offer advanced solutions for LVV manufacturing to support gene-editing T cells, from R&D to full-scale commercialization. Our expertise also extends to the manufacturing of non-genetically modified cells as well, including DC, NK and stem cells. We understand the complex world of compliance, so every CDMO service we provide is accompanied by robust regulatory support for your CMC package. From groundbreaking research to life-changing therapies, tcmc is your trusted partner in developing next generation therapies.
Taipei International Bakery Show
The Taipei Bakery Association (TBA), originally established as a dessert association in 1946, has long served as a cornerstone of Taiwan’s baking industry. It has played a pivotal role in promoting the industry’s growth and development across Taiwan. TBA is best known for organizing the Taipei International Bakery Show (TIBS)—an annual exhibition that highlights the latest baking trends and innovations in Taiwan, attracting professionals and enthusiasts from around the world. Beyond its support for Taiwan’s domestic industry, TBA actively fosters connections with regional and international counterparts. It engages with organizations such as the International Federation of Chinese Bakery & Confectionery Associations (IFCBCA) and the International Union of Bakers and Confectioners (UIBC). These collaborations are what make the association dynamic and resilient in the face of emerging global trends.
TaiMed Biologics
TaiMed Biologics, founded in 2007, is a leading biopharmaceutical developer and manufacturer in Taiwan. We have extensive monoclonal antibodies (mAb) development and manufacturing experiences and have successfully developed and commercially launched the first and only mAb for HIV treatment in the US and Europe (Brand name: Trogarzo®). We are proud to offer Contract Development and Manufacturing Organization (CDMO) services for biopharmaceutical companies to propel your important monoclonal antibody molecules from development to market launch. | TaiMed Biologics & Orient EuroPharma — Your Trusted Partners in Biologics and CDMO Services TaiMed Biologics (TaiMed) is a leading biopharmaceutical company specializing in the development and manufacturing of innovative biologics, with a strong focus on anti-HIV therapies. Our Key Strengths Include: – First-in-Class Innovation: Developer of Trogarzo® (ibalizumab), the world’s first long-acting monoclonal antibody for HIV, approved by the US FDA and EMA in 2018 and 2019. – Next-Gen HIV Therapies: Advancing long-acting monoclonal antibodies for HIV treatment and prevention. – Clinical-Stage Leadership: Leading candidate TMB-365/380 received Fast Track Designation from the US FDA in 2023 and has successfully completed Phase 2a, showing promising potential as a more confirming and durable HIV therapy. – Partnering Opportunities: Actively seeking global licensing and co-development partnerships with companies focused on HIV therapy. – CDMO Services: Leveraging decades of antibody development experience, TaiMed now offers end-to-end CDMO solutions, from early-stage development through to commercial manufacturing. This year, TaiMed is proud to co-exhibit with our long-term partner, Orient EuroPharma (OEP), to present integrated, high-quality biomanufacturing solutions that meet global standards. About Orient EuroPharma (OEP) Founded in 1982, Orient EuroPharma (OEP) is a Taiwan-based multinational pharmaceutical company specializing in prescription medicines, nutricare, and anti-aging products. OEP also offers comprehensive CDMO services, providing expertise from formulation development to commercial-scale finished product manufacturing. OEP’s CDMO capabilities include: – Formulation Development: Expertise in controlled-release formulations – Oral Dosage Manufacturing: Tablet, Capsule (granule/pellets/semi-solid/liquid filling) – Injectable Manufacturing: Liquid and lyophilized vials for high potency, cytotoxic and non-cytotoxic product Why Partner with OEP? – Regulatory Excellence: 15+ successful IND submissions in the U.S., China, and Taiwan; NDA projects ongoing – U.S.-Based R&D (San Diego Lab): Local formulation development & small-scale batch production for faster collaboration – Advanced Capsule Technology: Specialized in semisolid/liquid filling and banding for enhanced drug stability -Flexible Manufacturing Scale: Seamless transition from small-batch IND to large-scale NDA production – Quality Certification: Facilities certified by US FDA, PIC/S GMP, TGA, and MHRA With a strong track record of innovation, regulatory success, and manufacturing quality, TaiMed and OEP together offer a powerful CDMO partnership to support your drug development and commercialization goals. Visit us at our booth to explore collaborative opportunities!
TaiHao Medical Inc
Taihao Medical designs and develops AI medical software to help healthcare providers manage the increasing workloads. We focus on breast screening & diagnostic solution by utilizing ultrasound and LDCT AI solutions for lung disease. Our leading products include: 1.BR-FHUSTM Smart System (Free-Hand ABUS): AI for ultrasound breast screening 2.BR-ViewerTM for ABUS 3.BU-CADTM Decision Support: AI for ultrasound breast cancer diagnosis 4.Ti–LUNGTM Decision Support: AI for LDCT lung cancer screening & diagnosis Leading technology & expertise include: 1.Real-Time AI detects suspicious areas in Ultrasound images 2.Advisory Board include scientists & physicians in Taiwan, Japan, China, and USA We have received US FDA, Japan’s PMDA, Taiwan’s TFDA, China’s NMPA, and more than 10 patent licenses. We not only advocate our products to the world, integrate with AI marketplace, but also cooperate with government’s screening program, women breast centers, mammography clinics, insurance companies and ultrasound machine manufacturers. Taihao Medical’s shareholders include CDIB Capital Healthcare Ventures Limited, Japan ＣＥＳデカルト, Top Taiwan Venture Capital Co., Ltd. and CTBC Securities Venture Capital Co., Ltd., who are involved in our capital investing. We strive for integrating our AI products in different types of ultrasound devices. Furthermore, global market expansion has been one of our key landmarks for the past and upcoming years, supported by our strong technical team in related areas. They are highly professional and well experienced. “Early Detection, Early Treatment, Most Lives Saved” is Taihao’s Value Proposition. We aim to be one of the most successful AI Medical companies worldwide. Welcome to follow our Linkedin and notice our continuous milestone, the latest news, and employees’ life in Taihao Medical.